Get started
Work

176P Prognostic factors in patients with ovarian cancer enrolled in phase I clinical trials

Year: 2026
Type: article
Abstract: Ovarian cancer remains a lethal disease, often marked by platinum resistance, highlighting the need for innovative therapies and efficient selection of candidates for early-phase trials. Few studies have characterized outcomes or risks among ovarian cancer patients enrolled in phase I trials to better identify those most likely to benefit.
Source: ESMO Open
DOI: 10.1016/j.esmoop.2026.106183
Authors: M-A.L. Audisio, A. Leary, P. Pautier, Y. Loriot, R. Bahleda, A. Hollebecque, A. Marabelle, A. Patrikidou, J. Michels, F. Blanc-Durand, S. Postel-Vinay, M. Sakkal, A. Gazzah, V. Ribrag, C. Baldini, C.P. Massard, K. Ouali
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,910
OpenAlex ID: W7147212061
FWCI:
Cites:
Cited by:
Related to: